By MARLEY SEAMAN AP Health Writer NEW YORK (AP) – Biotechnology company Celgene said Wednesday it is expanding its array of cancer treatments with a deal to buy Abraxis BioScience Inc. for $2.9 billion in cash and stock. Celgene Corp.…

This grant competition is targeted at early-career research leaders, of any age, with 2-12 years of experience after their PhD. The researchers can be of any nationality as long as they are working, or moving to work, in Europe. The…

Source: http://www.science.doe.gov/News_Information/News_Room/2010/July%201_EarlyCareer.html WASHINGTON, DC – The U.S. Department of Energy (DOE) announced today it is accepting proposals for the second year of the DOE Office of Science Early Career Research Program to support the research of outstanding scientists early in…

source: http://online.wsj.com/article/SB10001424052748703571704575340880052218588.html NEW YORK—Arena Pharmaceuticals Inc. signed a deal for Japanese drug maker Eisai Co. to sell experimental weight-loss drug lorcaserin in the U.S., if it is approved by the Food and Drug Administration. The deal, the value of which…